| Endothelial dysfunction in diabetes: the role of reparatory mechanisms A Avogaro, M Albiero, L Menegazzo, S de Kreutzenberg, GP Fadini Diabetes care 34 (Suppl 2), S285, 2011 | 586 | 2011 |
| Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy GP Fadini, S Sartore, M Albiero, I Baesso, E Murphy, M Menegolo, ... Arteriosclerosis, thrombosis, and vascular biology 26 (9), 2140-2146, 2006 | 563 | 2006 |
| Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence C Tezze, V Romanello, MA Desbats, GP Fadini, M Albiero, G Favaro, ... Cell metabolism 25 (6), 1374-1389. e6, 2017 | 502 | 2017 |
| Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock KA Dyar, S Ciciliot, LE Wright, RS Biensø, GM Tagliazucchi, VR Patel, ... Molecular metabolism 3 (1), 29-41, 2014 | 443 | 2014 |
| The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived … GP Fadini, E Boscaro, M Albiero, L Menegazzo, V Frison, ... Diabetes care 33 (7), 1607-1609, 2010 | 402 | 2010 |
| DRP1-mediated mitochondrial shape controls calcium homeostasis and muscle mass G Favaro, V Romanello, T Varanita, M Andrea Desbats, V Morbidoni, ... Nature communications 10 (1), 2576, 2019 | 355 | 2019 |
| Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau GP Fadini, I Baesso, M Albiero, S Sartore, C Agostini, A Avogaro Atherosclerosis 197 (2), 496-503, 2008 | 339 | 2008 |
| Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats GP Fadini, S Sartore, M Schiavon, M Albiero, I Baesso, A Cabrelle, ... Diabetologia 49, 3075-3084, 2006 | 337 | 2006 |
| NETosis delays diabetic wound healing in mice and humans GP Fadini, L Menegazzo, M Rigato, V Scattolini, N Poncina, A Bruttocao, ... Diabetes 65 (4), 1061-1071, 2016 | 305 | 2016 |
| Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD (P) H oxidase via AMPK-dependent mechanism G Ceolotto, A Gallo, I Papparella, L Franco, E Murphy, E Iori, E Pagnin, ... Arteriosclerosis, thrombosis, and vascular biology 27 (12), 2627-2633, 2007 | 276 | 2007 |
| NETosis is induced by high glucose and associated with type 2 diabetes L Menegazzo, S Ciciliot, N Poncina, M Mazzucato, M Persano, B Bonora, ... Acta diabetologica 52, 497-503, 2015 | 250 | 2015 |
| Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens GP Fadini, S de Kreutzenberg, M Albiero, A Coracina, E Pagnin, I Baesso, ... Arteriosclerosis, thrombosis, and vascular biology 28 (5), 997-1004, 2008 | 224 | 2008 |
| Diabetes impairs stem cell and proangiogenic cell mobilization in humans GP Fadini, M Albiero, S Vigili de Kreutzenberg, E Boscaro, R Cappellari, ... Diabetes care 36 (4), 943-949, 2013 | 207 | 2013 |
| Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1 M Albiero, N Poncina, M Tjwa, S Ciciliot, L Menegazzo, G Ceolotto, ... Diabetes 63 (4), 1353-1365, 2014 | 153 | 2014 |
| An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy GP Fadini, SV de Kreutzenberg, E Boscaro, M Albiero, R Cappellari, ... Diabetologia 56, 1856-1866, 2013 | 150 | 2013 |
| Transcriptional programming of lipid and amino acid metabolism by the skeletal muscle circadian clock KA Dyar, MJ Hubert, AA Mir, S Ciciliot, D Lutter, F Greulich, F Quagliarini, ... PLoS biology 16 (8), e2005886, 2018 | 138 | 2018 |
| The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo L Menegazzo, V Scattolini, R Cappellari, BM Bonora, M Albiero, ... Acta Diabetologica 55, 593-601, 2018 | 137 | 2018 |
| Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes GP Fadini, M Albiero, L Menegazzo, E Boscaro, S Vigili de Kreutzenberg, ... Circulation research 108 (9), 1112-1121, 2011 | 126 | 2011 |
| Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo … GP Fadini, BM Bonora, G Zatti, N Vitturi, E Iori, MC Marescotti, M Albiero, ... Cardiovascular diabetology 16, 1-10, 2017 | 110 | 2017 |
| Concise review: perspectives and clinical implications of bone marrow and circulating stem cell defects in diabetes GP Fadini, S Ciciliot, M Albiero Stem Cells 35 (1), 106-116, 2017 | 105 | 2017 |
